Jean Jacques Vanden Eynde

11PUBLICATIONS
40CO-AUTHORS
ChemotherapyProteins and peptidesPharmacogenomicsBiologically active moleculesPreventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 06, 2021
COVID-19: Failure of the DisCoVeRy Clinical Trial, and Now-New Hopes?

Jean Jacques Vanden Eynde

|May 20, 2020
COVID-19: An Update About the Discovery Clinical Trial.

Jean Jacques Vanden Eynde

|Jan 08, 2020
2019: An Awesome Year for Pharmaceuticals.

Jean Jacques Vanden Eynde

|Jan 08, 2020
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-6.

Jean Jacques Vanden Eynde, Arduino A Mangoni, Jarkko Rautio

|Aug 02, 2019
Tafenoquine: A 2018 Novel FDA-Approved Prodrug for the Radical Cure of Plasmodium vivax Malaria and Prophylaxis of Malaria.

Annie Mayence, Jean Jacques Vanden Eynde

|Jul 03, 2019
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-5.

Arduino A Mangoni, Jean Jacques Vanden Eynde, Josef Jampilek

Pageof 2

Frequent Collaborators

4 joint publications

Arduino A Mangoni

4 joint publications

Tiziano Tuccinardi

4 joint publications

Simona Collina

4 joint publications

Diego Muñoz-Torrero